Applications for renewal of the authorisation of these active substances have been submitted in accordance with Regulation 844/2012. Due to delays in the decision-making and evaluation of the active substances for reasons not attributable to the applicants, the Commission has extended the validity of the authorisations. This is to prevent the authorisations for these active substances from becoming invalid before a decision on the renewal of the authorisations is taken.
We limit ourselves to listing the chemical active substances.
Active | CAS-No.: | extended until | Ref. |
Daminozide | 1596-84-5 | 15.09.2026 | 1) |
Pyraclostrobin | 175013-18-0 | 15.09.2026 | |
Buprofezin | 69327-76-0 | 15.12.2026 | |
Clodinafop | 114420-56-3 | 31.07.2027 | |
Cyflumetofen | 400882-07-7 | 15.10.2027 | |
Metam | 6734-80-1 | 15.11.2027 | |
Rescalure | 64309-03-1 | 18.05.2028 | |
Ametoctradin | 865318-97-4 | 31.05.2028 | |
Flupyradifuron | 951659-40-8 | 09.06.2029 | |
Mandestrobin | 173662-97-0 | 09.06.2029 | |
Copper compounds | 30.06.2029 | ||
Mandipropamide | 374726-62-2 | 30.06.2029 |
If the application for renewal of the approval of an active substance is rejected, the approval shall expire on the date specified in this Regulation or on the date of entry into force of the Regulation on non-inclusion, whichever is later.
The maximum residue levels currently in force remain unaffected by these extensions.
Author: Frank Mörsberger, AGROLAB GROUP